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Despite the fact that recent efforts to control/eradicate malaria have contributed to a significant decrease in the number of cases
and deaths, the disease remains a global health challenge. Vaccines based on mosquito salivary gland antigens are a potential
approach for reducing vector populations andmalaria parasites.TheAnopheles AGAP007752 gene encodes for a glucose transporter
that is upregulated during Plasmodium infection, and its knockdown decreases the number of sporozoites in mosquito salivary
glands. These results together with the fact that glucose is a vital source of energy suggested that a glucose transporter is a
candidate protective antigen for the control of mosquito infestations and Plasmodium infection. To address this hypothesis, herein
we investigate the effect of mice vaccination with an immunogenic peptide from mosquito glucose transporter on Anopheles
stephensi fitness and Plasmodium berghei infection. We showed that vaccination with a peptide of glucose transporter reduced
mosquito survival by 5% when compared to controls. However, the reduction in Plasmodium infection was not significant in
mosquitoes fed on vaccinated mice. The effect of the peptide vaccination on mosquito survival is important to reduce infestation
by malaria vectors. These results support further research on developing glucose transporter-based vaccines to reduce mosquito
fitness.
1. Introduction
Despite substantial progress in controlling malaria, the dis-
ease is still a public health problem in many countries, even
with a notorious reduction on malaria cases and mortality
rates of 41% and 62%, respectively, between 2000 and 2015
[1]. The Global Technical Strategy for Malaria 2016–2030
defined as primary targets the reduction of the number of
cases and deaths globally by at least 90% and the elimination
and prevention of reestablishment of malaria from no less
than 35 countries [1, 2].
Vaccines constitute the most efficacious intervention
towards infectious diseases control. While some blood-stage
vaccine candidates are presently under study, the Mosquirix
or RTS,S/AS01 was already approved by the European
Medicine Agency and is recommended by the WHO for
national immunization programs. This vaccine does not
confer full protection against Plasmodium falciparum, the
deadliest parasite causing human malaria, and, as such, it is
often used in combination with other control measures, such
as bed nets, indoor residual spraying, and antimalarial drugs,
depending on disease prevalence and parasite resistance data
from each country [3].
Transmission-blocking vaccines are a good example of an
alternative/complementary controlmeasure as these vaccines
may disrupt the parasite life cycle in the Anopheles sp.
mosquito. By reducing the number of infectious vectors and
parasite reservoirs, the transmission of Plasmodium declines
into the people community, leading to local group immunity
[4, 5]. The first malaria transmission-blocking vaccine were
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focused on surface antigens of parasite sexual stages but,
recently, target antigens of the mosquito have also been
investigated [6]. Due to the crucial role in parasite infection,
Anopheles midgut or salivary gland-specific antigens have
been used to interact with specific receptor-ligand peptides
that are essential to block parasite invasion or maintenance
[7–10].
Membrane transporter proteins are within the top five
protein classes againstwhich Food andDrugAdministration-
approved drugs are developed [11].These proteins encompass
diverse gene families, namely, major facilitator superfamily
transporters that allow shuttling of nutrient and metabolites,
which can provide a regulated electrochemical gradient
essential formosquito survival [12]. As occurs with facilitated
transporters and transmembrane integral proteins, glucose
transporters are likely to be glycosylated [13] and this may
modulate parasite recognition by the lobes of the mosquito
salivary glands [14, 15], leading to parasite adhesion and/or
invasion. Furthermore, these proteins allow passive passage
of glucose across the cell membrane enabling the required
metabolism of Plasmodium spp. for maintenance during
sporogonic cycle in the vector [16].
The AGAP007752 gene, which encodes a glucose trans-
porter (GT), is an example whose properties have been
previously evaluated [17].The gene coding for this GThad the
highest expression in Plasmodium-infected salivary glands of
A. coluzzii s.s. (A. gambiaemolecular M form) in both RNA-
seq and relative-qPCRassays in comparisonwith noninfected
groups [17], which suggests that the parasite is probably
modulating AGAP007752 expression to overcome invasion
and facilitate its maintenance in the target-organs [14, 16,
18, 19]. Moreover, Pinheiro-Silva et al. (2015) showed that
a significant reduction of AGAP007752 mRNA levels using
interference RNA results in a reduction of the number of
sporozoites by 44% in the salivary glands at 18 days after
infection [17]. These findings emphasized the importance of
AGAP007752 overexpression during Plasmodium infection
and its potential as a candidate protective antigen for the
development of a vaccine. Considering that malaria is a
vector-borne disease a dual-effect vaccine is an attractive
solution by targeting both mosquito and pathogen. In this
way, research should focus not only on the effect of vacci-
nation on transmission but also on the impact in mosquito
biological processes such as oviposition and survival. Herein,
we demonstrate that vaccination with an immunogenic and
conserved peptide of the GT protein (GTp) reduced malaria
vector survival suggesting its potential to be part of a mul-
tivalent vaccine for malaria control by reducing Plasmodium
transmission.
2. Materials and Methods
2.1. Ethical Statement. All institutional (Instituto de Higiene
e Medicina Tropical (IHMT) Ethical Committee and Divisão
Geral de Alimentação e Veterinária (DAGV), Art∘ 8, Portaria
number 1005/92 of 23rd of October), national (Decreto-
Lei number 129/92), and European (Directive 86/609/EEC)
guidelines for the care and use of laboratory animals were
followed.Animal procedureswere carried out under approval
number 023357 of DAGV.
2.2. Sequence Analysis. The amino acid sequence of
AGAP007752 protein was used to search for the orthologues
using Blastp (https://www.vectorbase.org/blast). A. darlingi,
A. sinensis, and A. stephensi amino acid sequences were
considered as orthologous and its sequences were obtained
from the VectorBase database (https://www.vectorbase.org/
blast). All sequences were aligned with MAFFT (v7) [22]
and all positions containing gaps were excluded with
GUIDANCE2 [23]. Molecular Evolutionary Genetics Anal-
ysis (MEGA, version 6) software was used to obtain the best
model to build the phylogenetic tree [21]. The Maximum
Likelihood tree was constructed based on a bootstrapping
method with 1000 replicates, LG model, and a proportion
of gamma distributed sites [20]. The tree generated was
visualized and edited using FigTree v1.4.3 [24].
2.3. Prediction of Antigenic Determinants and Peptide Syn-
thesis. The linear epitope of AGAP007752 sequence was
determined with near 75% accuracy based on the prediction
of antigenic determinants using the method developed by
Kolaskar and Tongaonkar [25] available at http://imed.med
.ucm.es/Tools/antigenic.pl. A putative antigenic GTp was
selected to be synthetically produced by ProteoGenix SAS
Company (Schiltigheim, France) for the immunoassays and
vaccine formulation.
2.4. Consensus Sequence Peptides. To check for similarity
between the antigenic epitope of A. gambiae GT protein,
previously selected, and the orthologue A. stephensi protein
(ASTE006385), the ClustalW program (http://europepmc
.org/abstract/MED/21988835) at the EBIwebsite (http://www
.ebi.ac.uk/Tools/msa/clustalo/) was used to align the amino
acid sequences.
2.5. Vaccine Formulations. Lyophilized antigen with a posi-
tive net charge (pH = 8.92) was reconstituted in 750𝜇L of
phosphate-buffered saline (PBS) and 50𝜇L of acetic acid 0.6%
(v/v) at a concentration of approximately 3.5 𝜇g/𝜇l peptide.
The peptide-based vaccine composition was mixed 1 : 1 with
Montanide ISA 50 V2 adjuvant (Seppic, France), at a final
peptide concentration of 25𝜇g/𝜇l. A control was prepared as
above but with PBS replacing the peptide.
2.6. Mice Vaccination and Infection Challenge. For immu-
nization, twelve five-week-old female Balb/c mice were
obtained from Charles River Laboratories and kept in the
IHMT animal facilities under controlled conditions. Mice
from control group (𝑁 = 6) were primed and boosted
intraperitoneally five times with 0.1ml each containing adju-
vant vaccine, every fortnight. A vaccinated group (𝑁 = 6)
was immunized with the GTp-formulated vaccine. Four days
after the last immunization, mice were infected with 107 P.
berghei ANKA parasitized red blood cells by intraperitoneal
inoculation or left uninfected as control.
BioMed Research International 3
2.7. Antibody Titer Determination. Before each immuniza-
tion and four days after the last immunization, mouse tail
blood was collected to obtain sera for determination of anti-
GTp antibodies titers by ELISA.
A high binding 96-well ELISA plate (Costar, MA, USA)
was coated with 0.1𝜇g of GTp protein diluted in 100𝜇l PBS
and incubated overnight at 4∘C. The plate was then washed
five times with Tris buffered saline (25mMTris HCl, 150mM
NaCl, and 2mM KCl) containing 0.05% (v/v) Tween 20
(TBST), blocked with 300 𝜇l of 5% (w/v) milk (Bio-Rad,
Hercules, CA,USA) at room temperature (RT) for 90minutes
and washed five times with TBST. For one hour at 37∘C,
serum samples were incubated, and, after washing the plate,
the secondary anti-mouse AP-conjugated immunoglobulins
(Sigma-Aldrich, St. Louis, Missouri, USA) diluted 1 : 5,000 in
TBST were added to each well for an incubation of one hour
at 37∘C. Washed plates were incubated with 1mg/ml of p-
nitrophenyl phosphate in substrate buffer (100mM glycine,
1mM MgCl2, 1mM ZnCl2, and pH 10.4) at RT in the dark.
Plates were then read at a wavelength of 405 nm in an
ELISA plate reader (Triad Series Multimode Detector, Dynex
Technologies, Chantilly, VA, USA) with Concert-Triad Series
software (version 2.1.0.17) at a wavelength 405 nm. Negative
and positive controls were included in the plates. Antibody
titers were determined at a 1 : 500 serum dilution and were
compared between GTp-immunized and control mice by
Mann–Whitney test (𝑃 < 0.05) (SPSS v24.0) [26].
2.8. Mosquito Rearing. A. stephensi mosquitoes (SDA-500
strain) were obtained from the IHMT insectary, reared at
20∘C in 70% humidity, under a 12 h light/dark photoperiod,
and fed ad libitum on a 10% glucose solution. For exper-
iments, only mosquitoes aged between 3 and 5 days were
used.
2.9. Anopheles stephensi Infection with Plasmodium berghei.
Mice blood samples were collected from mouse tail to
determine parasitemia, using light microscopy after staining
with Hemacolor kit (EMD Millipore, Germany). When the
parasitaemia reached 10–20% and 4–6 exflagellations/field
were observed, mice were anesthetized and used to feed and
infect female mosquitoes (𝑁 = 300/mice). Unfed female
mosquitoes were excluded, while fully engorged mosquitoes
were maintained at 19–21∘C and 80% humidity for P. berghei
development.
After blood meal, mosquitoes were kept in the cage with
egg cups for oviposition evaluation. To count the number
of eggs within groups, images from egg cups were taken
and analyzed using ImageJ 1.50i [27]. Mosquito survival for
18 days after feeding was also evaluated by counting the
number of survived mosquitoes between groups. Results
from mosquitoes fed on GTp-immunized and control mice
were compared by Mann–Whitney test (𝑃 < 0.05) (SPSS
v24.0) [26].
2.10. Determination of Plasmodium Infection. To check for
rates in parasite infection, at day 18 after blood-meal, cold
anaesthetized female mosquitoes were used and salivary
glands dissected to perform RNA extraction. RNA was
immediately extracted using GRS FullSample Purification
Kit (GRiSP, Porto, Portugal), quantified using a ND-1000
Spectrophotometer (NanoDrop ND1000,Thermo Fisher Sci-
entific, Waltham, MA), and stored at −80∘C. Using three
biological replicates of each condition (immunized or non-
immunized), total RNA (100 ng/𝜇L) was used to synthe-
size cDNA using the iScript cDNA Synthesis Kit (Bio-
Rad, CA, USA). qPCR reactions of 10 𝜇l were performed
in triplicate using IQ SYBR Green Supermix kit (Bio-
Rad, CA, USA) in a CFX96 Touch Real-Time PCR (Bio-
Rad, CA, USA) thermocycler. The following conditions were
used: an initial cycle of denaturation at 95∘C for 10min,
followed by 45 cycles of 95∘C for 15 seconds and 55∘C for
45 seconds to amplify the target Plasmodium 18s rRNA gene.
Fluorescence readings were taken at 62∘C after each cycle and
a melting curve (60–95∘C) was performed. To determine the
reaction efficiency, standard curves were constructed with 5-
fold serial dilutions of cDNA synthetized from total RNA
from a pool of samples. Relative expression levels mosquito
samples were normalized using the ribosomal protein S7
(60∘C) as reference gene and gene expression was analyzed
using the CFXManager Software version 3.1 (Bio-Rad, CA,
USA).
2.11. Immunofluorescence Assay. To evaluate the serum abil-
ity to detect the native antigen on A. stephensi salivary
glands, immunofluorescence assays (IFA) were performed.
Salivary glands were dissected and stored at 4∘C in 4%
(w/v) paraformaldehyde solution (Sigma-Aldrich, St. Louis,
Missouri, USA) diluted in PBS. For immunolocalization,
stored tissueswere placed in glass slides (BioMérieux, France)
and washed three times for 15 minutes with PBS. Salivary
glands were subsequently permeabilized with 0.2% (v/v)
Triton X-100 (USB, Cleveland, OH, USA) in PBS for 30
minutes at RT and washed with PBS (three times for
15 minutes) and a blocking solution of 3% (w/v) bovine
serum albumin (BSA) (Sigma-Aldrich, St. Louis, Missouri,
USA) in PBS was added for 30min at RT. After a washing
step, PBS, primary antibody from nonimmunized mice and
primary antibody from immunized mice, diluted (1 : 100)
in blocking solution, was applied to respective wells and
the slides were incubated overnight at 4∘C in the dark.
The secondary antibody, Alexa Fluor 647 (magenta) from
rabbit anti-mouse IgG (H+L) (Molecular Probes, Thermo
Fisher Scientific, Waltham, Massachusetts, United States),
diluted (1 : 100) in blocking solution was incubated for one
hour at RT. After three PBS washes, a drop of ProLong
Gold Antifade Reagent with 4󸀠,6󸀠-diamidino-2-phenylindole
(DAPI) (Invitrogen, Carlsbad, CA, USA) was placed over
the tissues and then slides were sealed with a coverslip.
After mounting, slides were placed in a humid dark box
until microscopy analysis to prevent drying and fluorescence
fading.
Sections of salivary glands were examined and pho-
tographed under 400x original magnification of a Nikon
eclipse 80i fluorescence microscope with Nikon DS-Ri1 cam-
era (Nikon Europe, Amsterdam, Netherlands) and appro-
priate filters (GFP/DAPI/CY5). Images were saved as high










Figure 1: Molecular Phylogenetic Analysis by Maximum Likelihood Method. Using the Maximum Likelihood method based on the
Le Gascuel 2008 model [20], the tree with the highest log likelihood (−3359.935) is shown. A discrete Gamma distribution was used to
model evolutionary rate differences among sites (5 categories (+G, parameter = 1.65)). The tree is drawn to scale, with branch lengths
measured in the number of substitutions per site.The analysis involved 5 amino acid sequences with respective VectorBase accession number:
AGAP007752: Anopheles gambiae, ASTE006385: A. stephensi, ASIS016443: A. sinensis, ADAC010569: A. darlingi, and CG15406: Drosophila
melanogaster (outgroup). All positions containing gaps and missing data were eliminated and bootstrap values for internal branches are
shown. Evolutionary analyses were conducted in MEGA6 [21].
quality TIFF files using NIS-ELEMENTS BR 3.2 (Nikon
Europe, Amsterdam, Netherlands) software, and the fluores-
cence intensity was compared between sections by ImageJ
1.50i [27]. Experiments were conducted in parallel and the
image acquisition parameters were the same.
3. Results and Discussion
3.1. Glucose Transporter in Anophelines. When searching for
potential targets to develop a mosquito stage vaccine, recep-
tors or transmembrane transporters are considered impor-
tant molecules to interrupt malaria transmission by targeting
parasite adhesion and/or invasion and/or maintenance in the
mosquito tissues [28, 29].
To determine the potential of AGAP007752 as a new
malaria control approach, we hypothesized that such gene
modulation could occur in other vectors of malaria, such as
A. stephensi and may interfere in Plasmodium infection and
vector sustainability.
Sequence alignment analysis demonstrates that the A.
gambiae GT is closely related to the A. stephensi protein
(ASTE006385) sharing 84% identical residues. Moreover, the
A. gambiae amino acid sequence shares a high similarity with
the A. sinensis (82%) and A. darlingi (70%). The evolutionary
history of the AGAP007752 protein was inferred (Figure 1).
These results highlight the high degree of conservation of
GT between anophelines and the potential to use this target
to block malaria transmission in different malaria vector
species.
Both AGAP007752 and ASTE006385 proteins belong to
the major facilitator superfamily responsible for the binding
and transport of sugar molecules (InterPro: IPR005829
and IPR005828) [30]. And, as mentioned in previous
studies, GT is a highly conserved transporter protein with
12 transmembrane domains and a unique N-linked oligosac-
charide side-chain present in a large extracellular loop
[17]. From all the predicted antigenic peptides of this protein,
the longest sequence with high polarity (hydrophilic) and
80% identity with theA. stephensi protein (ASTE006385) and
located between amino acids 190 and 260 (PDTPQTCL-
KKGRTAEAERSFMFYRGIRTQAEKTSALRQEFDNMEK-
FIEHNSGQNSRVTLADFKSREAKLGI) was selected for
synthesis. The synthetic peptide with a molecular weight of
8.17 KDa and a purity of 94.5% was then used for immu-
nization assays using A. stephensimosquitoes.
3.2. Localization of the GT Conserved Peptide in A. stephensi
during P. berghei Infection. An immunofluorescence assay
was performed to characterize the presence and localization
of GT in A. stephensi salivary glands during Plasmodium
infection (Figure 2). As negative control, nucleated and
infected SGs-cells were incubated with PBS and led to no
reaction inCy5 channel.Whenpreimmune serumwas added,
a diffuse fluorescence was observed in the Z-stack images
related to a nonspecific interaction between several proteins
and the polyclonal serum. As observed in Figure 2, the
fluorescence labeling is higher and specific on Cy5 filter
with anti-GTp serum. These results confirm the specific
interaction of antibodies with GTp in infected salivary glands
of A. stephensi, distributed in the membrane heterogeneous-
ly.
These results corroborated the presence of GT in A.
stephensi SGs, which is in accordancewith previous reports of
GT proteins as a key for parasite recognition in the sali-
vary glands [14, 15], providing a regulated electrochemical
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Figure 2: Fluorescence Microscopy of A. stephensi-Infected Salivary Glands Triple-Stained. Salivary glands were incubated with PBS,
preimmune and anti-GTp immune serum. Green fluorescence corresponds to GFP-expressing P. berghei, blue to the nuclei stained with
DAPI and magenta for Cy5-Alexa Fluor 647 to localize specific anti-GTp antibodies. The fluorescence intensity of SG Z-stack and merged
images was compared and then analyzed in the same conditions. A specific and localized recognition was evident when SGs were incubated
with the anti-GTp serum. Z-stack maximum intensity projections and a merge image of the three channels are given. Green: GFP-expressing
P. berghei. Blue: DAPI-counterstaining of the nuclei. Magenta: Cy5-Alexa Fluor 647. Bar: 25 𝜇m.
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Figure 3: Schematic Overview of Vaccination Trial. From twelve five-week-old female Balb/c mice, six were primed with PBS and the others
with GTp-formulated vaccine. Every fortnight, mice were boosted five times intraperitoneally. Four days after the last immunization, mice
were infected with P. berghei parasitized red blood cells by intraperitoneal inoculation or left uninfected as control. Blood samples were
collected to determinate antibody titers during immunization and after Plasmodium infection. For five days the infection was monitored
and when the parasitaemia reached 10–20% and 4–6 exflagellations/field were observed, mice were anesthetized and used to feed and infect
female mosquitoes (𝑁 = 300/mice). Mosquito survival and oviposition were assessed until the 18th day after blood meal (PBM).
gradient and nutrients to cell and parasite maintenance
[12].
3.3. Impact of GTp Immunization on Mosquito Infestations
and Parasite Infection. Vaccination trials were conducted to
elucidate the impact of GTp on mosquito oviposition and
mortality and P. berghei parasite infection of salivary glands
(Figure 3).
During subsequent GTp immunizations, the antibody
titers started to increase, even after pathogen inoculation
in mice (Figure 4), revealing a successful immune response
to GTp administration and no consequence in the parasite
erythrocytic cycle, as expected for an Anopheles-specific
antigen.
Immune-stimulated mice with or without Plasmodium
infection were used for female A. stephensimosquitoes blood
meal containing Plasmodium parasites and antibodies against
salivary GTp, and, then, the oviposition (Figure 5(a)),
mosquito survival (Figure 5(b)), and parasite infection (Fig-
ure 5(c)) were assessed.
As expected, as a carbohydrate and precursor in the
synthesis of glycogen, trehalose [31], and lipids [32], glucose is



































Figure 4:Mice Immunization with GTp after Challenge or Not with P. berghei. Comparison between GTp-immunized and control mice with
and without Plasmodium infection. Antibody titers were determined by ELISA assays and Plasmodium inoculation is represented with a red
arrow. Negative control is represented in a red dashed line. Statistical analyses were performed using Mann–Whitney test (𝑃 < 0.05). MONT
NINF: control mice without Plasmodium infection; MONT INF: control mice with Plasmodium infection; GTp NINF: GTp-immunized mice
without Plasmodium infection; GTp INF: GTp-immunized mice with Plasmodium infection.
essential for insect development, metabolism, and oogenesis
[33]. Therefore, disequilibrium in the levels of this ener-
getic component could alter survival, mating, host seeking,
and oviposition behaviors [34]. Besides, an impact on this
pathway could slightly decrease Plasmodium infection and
consequently improve the mosquito fitness.
Such imbalance probably happened during vaccination
trials, where anti-GTp antibodies interacted with the target
protein in A. stephensi salivary glands leading to a significant
increase of about 29% in the number of the eggs (𝑃 = 0.05)
(Figure 5(a)) and an average reduction of 4.67% in mosquito
survival during all replicas with significant impact between
the 5th and the 18th day (Log Rank/Mantel-Cox: 𝑃 = 0.085;
Breslow/Generalized Wilcoxon: 𝑃 < 0.0001; Tarone-Ware:
𝑃 = 0.003) (Figure 5(b)). Further studies could evaluate eggs
viability to focus on the effect of vaccination in the quantity
of glucose-metabolites inside the egg and subsequently egg
resistance desiccation effect [35].
Regarding the interference of GTp in Plasmodium-
infected SGs, our results point to a no statistical reduction in
P. bergheimRNA levels in theA. stephensi tissue (Figure 5(c)).
We believe that using higher amount of antibodies anti-GTp
acquisition bymosquitoes or even immunizingmice with the
full length protein would significantly increase the reduction
of the infection. Moreover, posttranslational modifications
like glycosylation, often occurring inGTs, cannot be ruled out
as potential efficiency promoter on the design of vaccines by
increasing protein immunogenicity.
4. Conclusions
To break the complex interplay during malaria parasite
transmission, a mosquito stage vaccine that works in tandem
with other interventions would be a critical tool for malaria
elimination/eradication. GTp is a conserved and immuno-
genic peptide that reduces A. stephensi survival, therefore
suggesting its potential for the control of different malaria
vectors. Further researchs on developing GT-based vaccines
need to be conducted to reduce mosquito survival and
parasite infection/multiplication.
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Figure 5:The Effect of Anti-GTp Antibodies on A. stephensi Mosquitos and Malaria Parasites. (a) Oviposition. Total number of eggs laid after
each experiment (𝑁 = 3) were counted and compared between GTp-immunized and nonimmunized groups. (b) Mosquito survival after
blood meal with anti-GTp immune serum and preimmune serum. (c). PlasmodiummRNA levels at 18th day after blood meal in SGs tissues.
Statistical analyses of (a) and (b) results were performed using Mann–Whitney test and for (c) using CFX Manager Software (∗𝑃 < 0.05).
MONT INF: control mice with Plasmodium infection; GTp INF: GTp-immunized mice with Plasmodium infection.
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